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ABSTRACT 
Ligament injuries are the most common sports injury in the United States. The 
current clinical practice for treating ligament injuries leaves many patients with 
significant pain and joint laxity for years following the initial injury. Controlled 
mechanical stimulation of the tissue after injury is necessary for robust healing, but the 
optimal mechanical environment for ligament healing is not fully understood. Alternative 
therapies, such as instrument assisted soft tissue mobilization (IASTM), offer a form of 
mechanical stimulation that is non-invasive and has shown promising clinical outcomes 
but the optimal dosage for IASTM treatments is unknown. The objective of this study 
was to develop in-vitro and in-vivo experimental devices that can help determine the 
specific mechanical loads that strengthen and accelerate ligament healing.  
Two devices were developed. The in-vitro device is a novel multi-axis mechanical 
stimulation bioreactor that can accurately apply tensile and combined tensile/compressive 
stress states to 3D fibroblast seeded tissue constructs. The bioreactor consists of two 
independently controlled actuators, one tensile, one compressive, a tablet computer, and 
data acquisition hardware. The bioreactor was validated using gelatin constructs to 
simultaneously apply cyclic forces from 0 – 0.2N with an accuracy of approximately 
0.01N, and a high degree of repeatability. The in-vivo device is a hand-held device to 
control the frequency and magnitude of applied force during IASTM treatments on rats 
after ligament transection. The device consists of a force sensor, tablet computer, and 
custom software to guide the application of user-specified loading parameters during 
vii 
IASTM treatments. The device accuracy was measured by applying a combination of 
force and stroke frequencies to rigid foam and was experimentally validated over a 3-
week animal experiment. The device was demonstrated to apply forces between 0 – 5N at 
frequencies from 0 – 1Hz with a high degree of accuracy and repeatability.  
The devices validated in this study provide a framework for future studies. The in-
vitro device can provide insight into the mechanobiological effects of different loading 
configurations on fibroblast seeded constructs, including the simultaneous application of 
tensile and compressive loading, which is similar to IASTM treatment. The in-vivo 
device will be used to perform animal studies that can assess the effects of varying 
applied force and frequency parameters during IASTM treatments. 
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CHAPTER ONE: INTRODUCTION 
1.1 Motivation 
Ligaments are bands of dense connective tissue that bind bone to bone to provide 
joint stability and guide smooth joint articulations. Through excess loading and overuse, 
ligaments are predisposed to injury. These injuries are accountable for over seven million 
hospital visits per year, and yearly medical costs of three billion dollars [1,2]. While 
many ligament injuries heal without intervention, up to 1/3 of patients experience pain 
and dysfunction for 3 years or more [3]. These lingering symptoms are a consequence of 
the slow healing process for ligaments, taking as long as one year to regain 50% of their 
original strength and in some cases never fully recovering to the strength of uninjured 
tissue [4]. Ligament damage can increase joint laxity and alter joint kinematics, 
increasing the risk for osteoarthritis, a painful disease that afflicts 27 million people in the 
United States  [3,5].  
The functional disabilities associated with injured ligament occur as a result of 
structural changes in the tissue [6]. Collagen type 1, the main load-bearing protein in 
ligament, becomes highly disorganized after an injury, in contrast to healthy ligament 
where the collagen is highly organized. The primary cells that repair and maintain these 
collagen networks in ligament tissue are fibroblasts. Fibroblast activity is regulated by 
mechanical stimulation [7] but the specific mechanical environment that is most 
beneficial to collagen remolding is not completely understood. Still, mechanical 
stimulation is necessary for complete injury healing as joint immobilization after injury 
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reduces the strength, stiffness, and size of healing ligament [8,9]. Instrument assisted soft 
tissue mobilization (IASTM) is a manual therapy technique that can be used to 
mechanically stimulate ligaments that are palpable through the skin. However, there is 
limited experimental evidence for the biomechanical and physiological effects of soft 
tissue mobilization treatments. As a consequence, there is no consensus on the optimal 
magnitude, duration, and frequency of force that should be applied to injured soft tissue 
during these treatments.  
1.2 Research Goal 
The purpose of this research is to develop methodologies to study the specific 
mechanical loads (e.g. force magnitude, duration, rate, and direction) that strengthen and 
accelerate ligament healing. This study focused on developing two experimental devices. 
The first device is for in-vivo testing of IASTM in animal studies. This device was 
designed to allow the user to target specific force magnitudes and frequencies during 
IASTM. The second device is a novel multi-axis bioreactor for 3D cellular constructs. 
This device was designed to apply repeatable force controlled stimulations for a variety 
of loading conditions.  
 The technology developed from this study will enable future research projects to 
identify and describe the specific mechanical environments that promote collagen 
remodeling and strengthen ligament. This knowledge can give insight into the functional 
effects and optimal dosage of IASTM, and provide a basis to elucidate extracellular 
matrix remodeling in all fibroblastic soft tissues. Additionally, the devices developed in 
this study have the potential to contribute to the field of tissue engineering, where optimal 
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mechanical stimulation regimes need to be determined for the development of functional 
tissue surrogates [10,11]. 
4 
 
 
CHAPTER TWO: BACKGROUND 
2.1 Ligament 
2.1.1 Ligament Structure and Function.  
Ligaments are dense bands of connective tissue that stabilize and guide joint 
articulations (Figure 1). Ligament is a viscoelastic material that exhibits time dependent 
properties including creep, stress relaxation, and hysteresis [12]. Ligaments structure is a 
combination of a ground substance, composed of water, lipids, proteoglycans, and other 
proteins, that is reinforced with a fibrous network of collagen and elastin [4,12]. Scattered 
among the longitudinally aligned collagen matrix are fibroblast cells [4,13]. Fibroblasts 
produce, repair, and maintain the extracellular matrix (ECM). Collagen represents 
approximately 75% of the dry weight of ligament and proteoglycans, elastic, 
glycoproteins and other proteins make up the remaining 25% [13]. Collagen type one 
accounts for 85% of the total collagen within ligaments and is the main load bearing 
Figure 1: Ligaments of the ankle joint [85] 
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constituent in the ligament [13]. The collagen fibers are highly aligned which produces 
non-linear anisotropic mechanical behavior in the tissue. 
Ligament tissue primarily supports mechanical loads in tension, but can also 
experience compression and shear in concentrically loaded ligaments such as the 
periodontal ligament [14]. Ligaments of the knee are commonly injured [1] therefore the 
physiological strains of ligaments in the knee have been thoroughly studied. During knee 
physiologic function, in movements such as side stepping and vertical drop jump, the 
anterior cruciate ligament (ACL) withstands tensile strains up to 6.1% and forces up to 
5% of body weight [15]. After an injury, the ligament can no longer support the same 
magnitude of mechanical load thus the joint must be supported by its natural articulating 
geometry, surrounding musculature, and other ligaments. As a result, the strains in 
surrounding uninjured ligaments can increase after an injury. In the knee joint, with a 
separated ACL, the strain through the medial collateral ligament (MCL) increases by 
1.8% when undergoing tibial translation [16]. Similarly, when the MCL is transected, the 
strain through the ACL increases by 0.7% during landing from a vertical jump [17]. 
Lastly, the strains through the injured ligament tissue can increase, because the injured 
ligament becomes more lax and less stiff  after an injury [18]. 
2.1.2 Ligament Wound Healing 
Ligament injuries account for over 7 million United States hospital visits annually 
[1]. Ligament injuries can be acute, from excess loading, or can occur slowly overtime 
due to overuse. Ligament healing occurs in three phases: inflammation and blood clot, 
matrix and cellular proliferation, and remodeling and maturation [12]. The first phase is 
characterized by the retraction of disrupted ligament ends, formation of a blood clot, and 
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release of growth factors to signal infiltration of cells. The proliferative phase is defined 
by hypertrophic fibroblastic cells producing granulation or “scar” tissue in the gap 
between the ligament ends. The scar tissue is highly disorganized and more vascularized 
than native ligament tissue. Over the course of a few weeks the collagen is remodeled and 
becomes better aligned but still does not have the strength or collagen composition of 
native ligament. Next, the remodeling and maturation phase occurs over months and even 
years after the initial injury. In this stage, the matrix is continuing to become more like 
native ligament but still has structural and functional differences including more 
disorganized collagen networks, altered collagen and proteoglycan composition, 10-20% 
reduced viscoelastic properties, and 50% reduced strength and stiffness even up to a year 
after injury [12] (Figure 2). 
 
2.1.3 Standard of Care 
The current standard of care for most ligament injuries starts with rest, ice, 
compression, and elevation (RICE) [19]. After the acute inflammatory stage (48-72 
Figure 2: Stress–Strain curves representing the mechanical properties of the 
medial collateral ligaments for sham-operated and healing MLCs at time periods 6, 
12 and 52, weeks [86] 
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hours), the joint is placed in a braced for weeks to months depending on the severity of 
the strain. Once significant pain has subsided, normal activities can be resumed. 
However, there is inconclusive evidence for the effectiveness of RICE during the acute 
healing phase [20]. Other new therapies are in development including ultra-sound, 
biological scaffolds, and stem-cell treatments [21–23]. While these treatments show 
promise, they are costly and are more invasive than other more conservative techniques, 
this limits the broad adoption of these treatments by health care providers. There is 
evidence that conservative treatments such as supervised physical therapy and manual 
therapy may be a more effective form of treatment than RICE [24,25]. Manual therapies 
are less constrained by cost and regulatory oversight and are used by 36 million people in 
the United States each year [26]. Instrument Assisted Soft Tissue Mobilization is a 
manual therapy technique that has shown to be effective at reducing pain and accelerating 
healing in ligament injuries [27,28]. 
2.2 Instrument Assisted Soft Tissue Mobilization 
2.2.1 Origins 
Massage therapy has been used for thousands of years as a way to treat 
musculoskeletal pain. In ancient Greece and Rome, small metallic instruments were used 
in bathhouses for therapeutic treatments [29]. Similarly, the traditional Chinese therapy 
known as “gua sha” uses a metal instrument to push or scape the skin and is thought to 
facilitate the supply of blood and oxygen to stimulated tissue [30]. IASTM is a treatment 
based on these principals of dynamically stroking damaged tissue with a blunt instrument 
to facilitate a healing response. IASTM encompasses a variety of techniques with 
different designations such as augmented soft tissue mobilization (Astym), fascial 
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abrasion technique, Graston technique, and sound-assisted soft tissue mobilization 
[29,31,32]. Historically, tools may have been made from stones or animal bones to apply 
stimulus, instruments used today are primarily made from stainless steel (Figure 3).  
2.2.2 Practical Application 
IASTM is a conservative and non-invasive technique [27]. The use of the tool 
allows the practitioner to maximize the force applied to the tissue with minimal 
discomfort or fatigue to therapist’s hands and upper body compared to other massage 
therapy techniques [33]. While there is some variation in the technique used between 
practitioners, the clinical protocol for IASTM will usually contain the following 
elements: warming of the tissue via exercise or hot pack, 40 – 120 seconds of IASTM 
therapy on an isolated soft tissue injury, stretching of the injured tissue, strengthening 
exercises for the joint with the injured tissue, and cryotherapy to reduce any initial onset 
of pain or excessive inflammation from the treatment. This is repeated 2 times per week 
for 4 – 6 treatments [34]. 
 
Figure 3: IASTM tools [87] 
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2.2.3 Clinical and Biological Effects 
In case studies IASTM has been shown to improve function and reduce pain for 
people with shoulder, Achilles tendon, and patellar tendinopathy [35–37], chronic ankle 
pain [38], chronic finger pain [28], and lower body muscle strains [39]. In animal studies, 
IASTM has been shown to accelerate the rate of tissue healing [27], increase the total 
number, recruitment and activation of fibroblasts in the injured tissue [40,41] and 
increase the number of tissue-resident mesenchymal stem cells in the arterial ad-ventitia 
and micro-vessels of the injured tissue by threefold [42]. Because fibroblast originate 
from mesenchymal stem cells [43], this gives compounding evidence that IASTM is 
associated with increased fibroblast activity. 
2.2.4 Mechanisms 
Despite positive clinical outcomes, there are few experimental studies of the 
mechanisms and functional effects of IASTM on injured tissue. There are two main 
hypotheses for the functional effect of IASTM. One hypothesis is that the main functional 
effect of IASTM is the removal of scar tissue adhesions in and around the injured tissue. 
Scar tissue is thought to limit perfusion to the injured soft tissue, which restricts the 
supply of oxygen and nutrients, and interferes with collagen synthesis and regeneration of 
tissue, which can cause incomplete functional recovery of the tissue [2,44]. This 
hypothesis is supported by animal studies showing increased cellular activity in the tissue 
[27,40,41] and micro-vasculature in the tissue [29,38,45]. Another hypothesis is that 
IASTM functions from restarting the healing process by causing localized inflammation 
in the damaged tissue [29,38]. An adequate amount of inflammation in the tissue can 
facilitate healing through the signaling of fibroblasts to synthesize collagen [46]. In 
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addition, soft tissue inflammation has been shown to be associated with increased 
numbers of fibroblasts. This fact, in combination with studies showing increased 
fibroblast activity after IASTM [27,40,41], support this hypothesis. However, Vardiman 
et al. (2014)[47] reported no significant increase in inflammatory signaling after IASTM 
treatments. A third, less investigated hypothesis, is that the forces produced during 
IASTM treatments create an environment that signals fibroblasts to remodel the extra 
cellular matrix and reform strong collagen networks. Fibroblasts have been shown 
respond to both tensile and compressive mechanical loads [14,48–53]. However, 
fibroblasts response to more complex loading has not been thoroughly investigated. 
IASTM treatments create a complex dynamic mechanical environment that involves 
tensile, compressive, and shearing forces. The in vitro and in vivo devices presented in 
this study provide frameworks to investigate the effects of complex loading on fibroblast 
activity and mechanical changes in healing ligament 
2.3 Mechanobiology 
2.3.1 Mechanotranduction 
The fibroblast cells in the ligament are signaled to produce, repair, and maintain 
the ECM by sensing the mechanical forces transferred through the ECM. This process by 
which cells convert mechanical stimulus to biochemical activity is known as 
mechanotransduction [54,55]. The process of mechanotransduction and matrix 
remodeling is seen is many different musculoskeletal tissues including bone, ligament, 
muscle, and tendon [54]. Mechanical loading can increase the size and strength of 
musculoskeletal tissues while the absence of load can cause  the tissue structure to 
become weak [8,9,54,56]. The mechanical environment that the cells experience within 
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ligament during physiologic function is complex and can include components of force 
from tension, compression, and shear due to fluid flow throughout the tissue during 
motion. The macro scale tensile strains in ligament during physiological loading have 
been well quantified [16,17] but compression and fluid shear mechanical loads have been 
less investigated. Although the mechanical environment cells experience within native 
tissue is complex, to clearly understand the effects of mechanical stimuli on 
mechanosensitive cells and EMC remodeling, the mechanical stimuli applied to the cells 
must be isolated and precisely controlled.  
2.3.2 In –Vitro Experimental Models  
The in-vivo environment is extraordinarily complex. As a consequence, the 
response of cells to mechanical and chemical stimulation has largely been studied using 
in-vitro cell culture systems. Traditionally, 2D cell cultures have been used as the 
primary in-vitro experimental model because they provide a simple and efficient method 
to study cellular responses from mechanical and chemical stimulation [57]. In 2D cell 
culture, cells are typically mechanically supported in a petri dish or glass polystyrene. 
While these 2D models have contributed greatly to the understanding of cell behavior, 
there is growing evidence that the results from these models can deviate significantly 
from the in-vivo response [57]. In three-dimensional cell culture, cells are suspended in 
different types of laboratory created ECM. 3D gel models provide a more realistic 
biochemical and biomechanical microenvironment than a 2D model while still allowing 
control over culture conditions, specimen composition, and boundary conditions [57–59]. 
For the modeling of soft tissues, such as ligament and tendon, fibroblasts are often seeded 
within an ECM made of collagen [53,57,60]. These 3D models are valuable because not 
12 
 
 
only can the effects stimulation be measured in substrate mechanical properties changes 
and chemical signaling, changes in the microstructure of the ECM can also be observed 
[53]. While these models provide an effective experimental tool to understand the effects 
of mechanical stimuli on cells in a 3D environment, they do not have the same level of 
structural and composition complexity, nor do they have the mechanical strength of 
native soft tissues. 
A wide variety apparatuses have been developed for the mechanical stimulation 
of cell and tissue cultures. These devices can apply multiple different mechanical stimuli 
including: compression (hydrostatic pressure or direct compression), longitudinal stretch, 
bending, substrate distention, fluid shear stress, and biaxial stretch [61]. Newer devices 
have sought to apply more complex loading to tissue cultures such as combined 
tension/compression and compression/shear [62,63]. Other systems have been developed 
to apply tensile stimulation while also altering the chemical environment around the 
tissue culture to more closely mimic the in vivo environment [64]. In chapter three of this 
study a novel multi-axis bioreactor for the stimulation of 3D fibroblast seeded tissue 
constructs is developed. 
2.3.3 In-Vivo IASTM Experimental Models 
While the mechanical environment during an in-vivo experimental model cannot 
be as precisely controlled as the in-vitro environment, in-vivo experiments provide results 
that are more directly transferable to clinical practice, but still provide quantitative data 
that cannot be obtained from a clinical study. In-vivo IASTM experiments generally 
involve three components: chemically or surgically induced soft tissue injury, IASTM 
treatments applied to injury, and testing (mechanical, biochemical and histological) to 
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determine functional effect. Despite the fact that variation in pressure applied during 
IASTM has been shown to affect fibroblast activation [65] and in-vitro studies have 
shown that both magnitude and rate of force application effect the response of fibroblasts, 
[49,52,66] few in-vivo studies have even attempted to control the mechanical loads 
applied during IASTM. This makes it impossible to connect the biochemical and 
mechanical changes from IASTM to specific loading conditions during the treatment. As 
a result, there are no quantitative guidelines for the magnitude or rate at which force is 
applied during the IASTM. This is due in part to the absence of practical tools to control 
applied forces during IASTM and other massage treatments. 
Multiple techniques and devices have been utilized to control applied force during 
soft tissue mobilization. One technique was to use an IASTM tool on a force plate prior 
to treating the subject to get a kinesthetic feel for the amount of pressure applied [27,67]. 
This technique allows for some qualitative control but provides no feedback during the 
treatment and does not measure the applied force. Devices using pressure transducers 
have been developed to evaluate pressure applied during treatment, but these devices 
offer no feedback to control pressure or frequency [40,68]. Zoest et. al. [69] presented a 
handheld device that measured contact forces during massage using a 3D piezoelectric 
strain gauge. However, the device had problems with force drift and measurement 
accuracy and did not give the practitioner any feedback during treatment to control the 
force applied. Tuttle et. al. presented a device that did provide feedback during massage 
but was limited to use in massage using the finger tips. However, these handheld devices 
[69,70] were not designed for IASTM treatments, instead they were intended for use 
during muscle tissue massage. 
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Other researchers have made robotic systems to measure force during massage. 
Wang et. al developed a robotic system that applies massage like strokes using a stainless 
tip and controls for compressive force using a feedback loop [71]. The device moves 
along two axes, in the x and z directions but only controls for the compressive force. 
Additionally, animals are required to be strapped down in a specific position next to the 
device base in order to have the force properly applied. Similarly, Zeng et al[72] 
developed a pneumatic system to control the applied force during compressive and 
lengthwise strokes. The device used a metal roller, or “kneading wheel”, to apply the 
force across the muscle tissue and was design for use with rabbits. Both of these devices 
could accurately control force but they do not replicate the IASTM protocols utilized in 
clinical settings because they only focus on muscle tissue massage as opposed to soft 
tissue treatments [71,72]. In addition, they require specific positioning of animal subjects 
and as such are limited in their ability treat different joints. In chapter three of this study, 
a practical hand-held device is presented that allows for the user to accurately control 
both force and frequency during IASTM treatments. This tool provides the basis for 
future in-vivo experiments on the optimal mechanical loads that should be applied during 
IASTM.
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CHAPTER THREE: MULTI-AXIS MECHANICAL STIMULATION BIOREACTOR 
FOR STIMULATION OF 3D CELLULAR CONSTRUCTS 
3.1 Introduction  
3.1.1 Mechanical Stimulation of Fibroblasts 
There are numerous factors that can be manipulated when applying mechanical 
stimuli to cells including: axis of loading, dynamic or static loading, load magnitude, 
frequency, and total duration. Tension has been the primary axis of stimulation studied 
for the fibroblast based 3D in-vitro models [49,51,53,58,59,73–75]. These in-vitro 
models have shown that fibroblasts will remodel collagen fibers within the ECM to align 
along the axis of tensile stress [53,58,59]. In addition, dynamic mechanical stimulation 
increased construct stiffness, collagen production, and cell viability more than static 
stimulation [49,51,52,74,75]. Furthermore, peak applied strains between 2.5 – 5% and 
frequencies between 0.1 – 0.5 Hz were found to be optimal for increased construct 
stiffness [49,52]. Lastly, continuous dynamic strain without any period of rest, was found 
to be detrimental to construct stiffness and cell viability [49,52]. Compression has 
received less attention despite its critical role in the mechanobiology of fibroblasts in 
fibrocartilaginous and concentrically loaded ligament tissue. Dynamically applied 
hydrostatic pressure and confined compression of fibroblasts have shown increased gene 
expression for some collagen proteins and increased cell viability [14,48]. The effects of 
more complex loading on fibroblasts is still unknown. 
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3.1.2 Quantifying Mechanical Stimuli 
The current approach for evaluating how fibroblasts respond to mechanical 
stimuli is to apply a specific magnitude of strain in one axis. However, this approach does 
not completely quantify the stress states that are applied to the tissue construct or the 
cells. In this study, we aim to describe the stimulation applied to cells in terms of 
deviatoric stress (shear stress) and dilatational stress (volumetric stress). The rationale for 
this approach comes from evidence that shear stress is the primary driver of physical 
phenomena such as material yielding. Through experimentation on ductile materials, 
deviatoric strain energy or distortion energy has been shown to be the primary factor for 
predicting material yielding [76]. However, in fibroblasts the effects of deviatoric vs 
dilatational stress on collagen synthesis and ECM remodeling have not been decoupled.  
3.1.3 Deviatoric vs. Dilatational 
Any strain or stress tensor can be described in terms deviatoric and dilatational 
components. When the deviatoric and dilatation components are added together they give 
the original tensor back (Eq. 1-4). Deviatoric strain is the component of strain that 
describes a shape change at a constant volume, while dilatational strain is the component 
of strain that describes a volume change. Similarly, deviatoric stress is the component of 
stress that causes shape change at a constant volume and dilatation stress is the 
component of stress that causes volume change (Figure 4).  
𝝐 =  𝝐′ + 𝝐𝒅𝒊𝒍  (1) 
𝝐𝒅𝒊𝒍 =  
𝝐𝟏𝟏+𝝐𝟐𝟐+𝝐𝟑𝟑
𝟑
 (2) 
𝝈 =  𝝈′ + 𝝈𝒅𝒊𝒍  (3) 
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𝝈𝒅𝒊𝒍 =  
𝝈𝟏𝟏+𝝈𝟐𝟐+𝝈𝟑𝟑
𝟑
  (4) 
 
Figure 4: Deviatoric and dilatational components of a stress tensor 
Even though deviatoric stress is related to deviatoric strain, in anisotropic 
materials the strain produced by a pure deviatoric stress is not a pure deivatoric strain. In 
anisotropic materials predicting the strain would require an accurate measure of the 
Poisson’s ratio of the material so that specific levels of deviatoric and dilatational strain 
could be predicted and targeted in an experiment. Because most 3D in-vitro constructs for 
ligament have a fibrous structure composed of collagen similar to ligament they have 
Figure 5: Moor's circles and 3D stress elements for (A) tensile stress, (B) 
compressive stress, (C) and tension + compressive stress 
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anisotropic material behavior. Additionally, matrix strain transmission to cells has been 
shown to vary based on the structure and material properties of the of the ECM in 3D in-
vitro constructs made from collagen and fibrin gels [77–79]. Consequently, accurately 
controlling the deformations of the tissue construct and the cells inside would be 
challenging and require a multiscale approach to verify the accuracy of the applied strains 
and the strain transmission from the tissue construct to the implanted cells. However, the 
traction forces on the cells from the ECM in collagen gels has been shown to be 
independent of the ECM density and stiffness [77]. This is significant because the stress 
applied to the tissue construct will be the same stress applied to the cells within the 
construct. Therefore, using a stress control approach will allow the stress states applied to 
the ECM to be accurately quantified. Additionally, specific deformations during IASTM 
cannot be targeted but applied stress can be controlled. Thus, the results from a stress 
controlled in-vitro model would be more transferable to a controlled in-vivo experiment 
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. From principals of mechanics, it can be shown that a one-dimensional tensile 
stress and one-dimensional compressive stress will produce the same magnitude of out of 
plane deviatoric stress (Figure 5 A, B). Applying a tensile and compressive stress of the 
same magnitude increases the out of plane deviatoric stress by two-fold and creates a 
purely deviatoric stress, while the magnitude of the normal tensile stress remains the 
same (Figure 5 C). Accordingly, the effects of deviatoric stress could theoretically be 
compared through looking at the effects of both loading configurations, pure tensile 
stress, and combined tensile/compressive stress. While the in-situ forces produced by 
IASTM have not been accurately quantified, from visual observation, the association can 
be made that IASTM produces a highly deviatoric stress state due to the applied 
compression and shear from the IASTM tool and the natural tension from the ligament 
tissue (Figure 6).  
Figure 6: Theoretical mechanical loading conditions created by IASTM. The 
size of the deviatoric stress is increased compared to combined 
tension/compression due to added shearing forces. 
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The objective of this study was to design and validate a multi-axis mechanical 
stimulation bioreactor that can accurately apply tensile and combined tensile/compressive 
stress states to 3D fibroblast seeded tissue constructs. 
3.2 Methods 
3.2.1 Bioreactor Design Criteria 
There were numerous design criteria specified for the bioreactor (Table 1) 
Table 1: Bioreactor design criteria 
Design Criteria Rationale 
Accurately controls simultaneous 
application of cyclic tensile and 
compressive load to 3D Gels at loads 
magnitudes between 0 – 1N and frequencies 
between 0 – 1Hz 
The highest failure force (N) seen in the 
literature for collagen gel constructs was 
approximately 0.85N [49] 
Can operate for 6 hours per day for up to 14 
days 
~14 days is the average duration of 
stimulation for cell seeded tissue 
constructs in the literature [49,50,52] 
Can perform uniaxial on tensile test samples 
using displacement control 
Necessary to mechanically characterize 
tissue constructs and determine 
functional effects of stimulation 
Can fit inside of a standard incubator and 
withstand environmental conditions (40 x 
40 x 50 cm, 37℃, 99% Humidity, and 5% 
CO2) 
In order to maintain cell viability during 
stimulation samples need to be an 
incubator environment 
Tissue stimulation chamber must be able to 
withstand sterilization techniques and 
maintain sterility during use. 
In order to prevent contamination during 
cell culture the chamber must be properly 
sterilized 
Tissue stimulation chamber must allow the 
sample to be covered in cell culture media 
during stimulation 
In order to maintain cell viability and 
prevent contamination the tissue 
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constructs must be covered in cell culture 
media during stimulation 
Tissue stimulation chamber can 
accommodate varying sample sizes 
Allows flexibility for the device to be 
used for stimulating and mechanically 
testing samples of different size and 
material 
 
3.2.2 Bioreactor Construction 
The bioreactor is primarily composed of plastic or corrosion resistant metal to 
prevent corrosion and withstand ethylene oxide sterilization (Figure 7). The base plate, 
sample chamber supports, and shaft connecting horizontal load sensor to the grip were 
machined from polyoxymethylene (acetal) plastic. The clear plastic components 
connecting the load sensors to the actuators and the outer walls of the sample chamber 
were machined from acrylic. All black plastic components were 3D-printed using 
Polylactic acid (PLA) filament. The support structure for the compressive actuator and 
the shaft between the vertical load sensor and loading platen was machined from 304 
stainless steel. The loading platen and the white plastic covering the compressive loading 
platform are made from PTFE. All screws used in the tissue stimulation chamber are 
nylon, while all other screws are 304 stainless steel. 
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 The tensile and compressive assemblies are driven by high precision voice coil 
actuators (SLA-25-010-55-1, SMAC, Carlsbad, CA). Voice coil actuators were chosen 
because, unlike standard gear driven actuators, voice coil actuators have no mechanical 
components driving the motion of the actuator. Thus, they have no backlash and are ideal 
for applications involving long duration cyclic motion because the internal components 
experience minimal wear overtime. This particular voice coil actuator was selected for its 
range of motion (10mm), range of force (4N peak, 1N continuous), and high-resolution 
positioning (1µm). The actuators are powered via a 24V power supply (Keysight 
E3631A) and 2 single axis amplifiers (LAA-5, SMAC, Carlsbad, CA). Connected to the 
Figure 7: Image of bioreactor for force controlled multi-axis stimulation of 
collagen gels 
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tensile and compressive actuators are LRM200 force sensors (1N capacity, FUTEK Inc., 
Thomas, Irvine, CA) used to monitor the applied force to the specimens. 
The tensile actuator is rigidly held to a manually adjustable horizontal translator 
via a 3D printed connector plate for flexibility in positioning the grip attached to the 
specimen. The tensile shaft is connected to through the wall of the tissue stimulation 
chamber and secured to the tensile grip via nylon set screw. The adjustable tensile grip 
has four fixed-position threaded holes to that allows specimens between 10 – 40 mm in 
length to be accommodated using the same grip. The tensile grips interface with the 
specimens by directly compressing the ends of the sample between a stationary base and 
top clamp secured via nylon screws. The compressive actuator is rigidly held to the 
manually adjustable two-axis translator to allow flexibility in positioning the compressive 
loading platen. The loading platen is secured to the load cell via a threaded shaft and a 
set-screw. The sample rests upon the compression platform. The compression platform 
surface is covered with a PTFE sheet, secured using cyanoacrylate, to provide a bio-inert 
surface for the specimens to be stimulated and to reduce friction during compressive and 
tensile loading. The loading platen interfaces with the sample via manual adjustment of 
the platen onto the surface of the sample using the translator attached to the compressive 
actuator. 
The bioreactor controls were programmed using LabVIEW Professional 
Development Software and the Soft Motion Module. The actuators were controlled using 
a Compact-Rio 9024 and two NI9514 servo interface drives (National Instruments Co., 
Austin, TX). Force measurements were recorded using a four channel NI9269 strain 
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gauge module. Force controlled stimulation was achieved through a custom program. The 
stimulation is initiated by sending two synchronized sinusoidal position waveforms at 
user specified displacement for each waveform, one to the tensile actuator and one to the 
compressive actuator. In order to create a purely deviatoric stress state from a 
synchronized tensile and compressive stress, the waveforms were sent so that the peak 
compressive force and the peak tensile force are reached at the same time (Figure 8). The 
program monitors the max peak force and the minimum peak force reading for each force 
waveform one time every cycle and shifts the start position and amplitude of each of the 
position waveforms simultaneously until the peak force reading is within a user specified 
threshold of the target force value. The force waveforms are fit with a smoothed cubic 
spline prior to calculating the peak force values to reduce the effects of load cell noise 
and vibration on the sensitivity of the position waveform shifting. The waveform shifting 
logic can be turned on or off at any time and the program can simply be used to monitor 
Figure 8: Synchronized tensile and compressive force waveforms 
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the position and force waveforms. This allows the system to seamlessly switch between 
position or force controlled stimulation. In addition to cyclic stimulation, the system can 
also be used in displacement control for uniaxial mechanical testing of specimens. 
3.2.3 Bioreactor Performance Testing 
Three experiments were conducted to assess the performance of the bioreactor. 
Gelatin samples in a dog bone shape were created to conduct all validation tests (Figure 
9). Gelatin was chosen because it can easily be created with varying geometry and 
numerous samples can be made quickly.  
The first test evaluated the accuracy of the force controlled stimulation. Two test 
groups of tensile and compressive force waveforms were evaluated where the frequency, 
peak force, and amplitude of the waveforms were manipulated (Figure 10). 
Figure 9: Gelatin sample used for validation with 16 mm length (L), 8 mm 
width (w), and 4.5 mm thickness. Gelatin concentration 1 gram of gelatin per 10 ml 
of water 
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The first group tested waveforms with peak forces ranging from 0.05 – 0.2 N and 
frequencies from 0.25 to 1 Hz (Table 2). 
The first test group was performed using a rubber band sample in addition to the gelatin 
sample, but only the tensile waveform was applied to the rubber band sample to measure 
the performance of the system using a non-viscoelastic material. The second group 
targeted a constant peak force while changing the amplitude to isolate the effects of 
changing force amplitude on accuracy (Table 3). 
Figure 10: Sample force waveform with labeled parameters. 
Table 2: Force accuracy test group 1, target force waveform parameters. Each 
peak force and amplitude combination was tested at each frequency (12 waveforms 
total)  
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For each test, the force controlled stimulation program was first allowed to reach 
equilibrium. Equilibrium was defined as the point at which both force waveforms were 
within 0.01N of their target for at least five cycles. Force measurements were recorded 
for 30 cycles at each target force waveform, for a total of nine trials. A Fourier series 
summation was used to fit the force measurement data with a non-linear least squares 
fitting method [80] every three cycles, yielding ten fitted curves for each trial. The peak 
Table 3: Force accuracy test group 2, target force waveform parameters. Each 
peak force and amplitude combination was tested at each frequency (9 waveforms 
total) 
Figure 11: Sample of a Fourier series curve fit for used for calculating the mean 
peak and amplitude of the force waveforms during the bioreactor performance tests 
(R = 0.92) 
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force and amplitude for each trial were determined directly from the fitted curve and the 
mean for each trial was determined by taking the mean peak and amplitude of each of the 
ten fitted curves (Figure 11). The error of the peak and amplitude of each trial was 
defined as the absolute value of the difference between the target force and the measured 
force (|Forcemeasured-Forcetarget|). 
The second test evaluated the repeatability of the force controlled stimulation over 
a long duration. The bioreactor ran for six hours (10800 Cycles) with target force 
parameters of 0.5Hz, 0.15N peak force, and 0.07N amplitude. Force measurements were 
recorded for 1800 cycles every hour of operation. 
The third test observed the average number of cycles it takes for the force 
controlled stimulation to reach equilibrium. The force waveform parameters were a 
frequency of 0.5Hz, peak force of 1N, and amplitude of 0.045N. Ten trials were 
performed and the number of cycles at equilibrium was recorded for each trial.  
3.2.4 Statistical Tests 
The effect of frequency and target peak force on the peak force and force 
amplitude error were analyzed using one-way ANOVA tests with Games-Howell post 
hoc tests to account for unequal variance between test groups. The effect of target force 
amplitude on force amplitude error was also examined using one-way ANOVA tests and 
Games-Howell post hoc tests. The overall error in applied peak force and force amplitude 
for tensile and compressive force waveforms was compared using a one-way ANOVA. 
The effect of time point on load error was analyzed using a repeated measures ANOVA 
with a Bonferroni post hoc test. For all statistical tests, significance was set at p<0.05 
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Results 3.3 
From test group one, using the rubber band sample in only tension, the average 
error of the peak forces and force amplitudes across all waveform frequencies was less 
than 0.003N (Figure 12). The average error of the peak forces and force amplitudes 
across all waveform peak forces was less than 0.003N (Figure 13). 
 
Figure 12: The accuracy of the tensile waveforms averaged over all tested peak 
forces and grouped by the waveform frequencies (N=40) from test group one using 
the rubber band sample (*= significant difference). (A) Accuracy of the peak force 
( * p = 0.000) (B) Accuracy of the amplitude (All groups were significantly different 
p = 0.000) 
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 From test group one, using the gelatin sample, the average error of the peak forces 
and force amplitudes across all waveform frequencies was less than 0.005N (Figure 14). 
For both peak force error and force amplitude error was significantly lower at 0.5Hz for 
tension and compression (Figure 14). The error of applied peak force was less than 
0.005N for all target peak forces (Figure 15). There were no significant differences 
Figure 13: The accuracy of the tensile waveforms averaged over all tested 
frequencies and grouped by target peak force (N=40) from test group one using the 
rubber band sample. (A) Accuracy of the peak force (*p=0.05) (B) Accuracy of the 
force amplitude (*p = 0.000) 
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between the peak error of all the tested peak forces (Figure 15A). The error of the 
amplitude was less than 0.005N across all tested peak forces (Figure 15B).  
 
The error of amplitude for an applied tensile peak force of 0.05N was 
significantly higher than the other peak forces (Figure 15B) p = 0.013). There were no 
Figure 14: The accuracy of the tensile and compressive waveforms averaged over 
all tested peak forces and grouped by the waveform frequencies (N=40) from test 
group one using the gelatin sample (*= significant difference tension • = significant 
difference compression). (A) Accuracy of the peak force (* p = 0.05, • p = 0.05) (B) 
Accuracy of the amplitude (* p = 0.005, • p = 0.001) 
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significant differences between the tensile or compressive average peak force or 
amplitude error (Figure 16). 
 
The error of the force amplitude while the peak load was held constant was also 
below 0.005N for all tested load amplitudes (Figure 17). Both the tensile and 
compressive waveforms were most accurate for a target amplitude of 0.075N (Figure 17). 
Figure 15: The accuracy of the tensile and compressive waveforms averaged over 
all tested frequencies and grouped by target peak force (N=40) from test group one 
(*= significant difference tension • = significant difference compression). (A) 
Accuracy of the peak force. (B) Accuracy of the force amplitude (*p = 0.013) 
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The force control stimulation remained accurate to within less than 0.01N for 
peak force and amplitude over all time points (Figure 18). The compressive peak error 
was significantly better on the fifth hour of the test (Figure 18, p = 0.000). The tensile 
amplitude error was significantly better at the beginning of the test (Figure 18, p = 0.000).  
The mean number of cycles it took for the force controlled stimulation to reach 
equilibrium was 65.3 ± 9.2 cycles. 
 
Figure 17: Comparison of average accuracy between tensile and compressive 
waveforms (N=120)  
Figure 16: Accuracy of applied load amplitude for a constant peak load of 0.15N 
(N=30). (*= significant difference tension • = significant difference compression). 
(***, *, * p = 0.001, • p = 0.01) 
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Discussion 3.4 
The purpose of this study was to develop and validate a multi-axis bioreactor to 
apply force controlled stimulation to fibroblast seeded tissue constructs. The bioreactor 
was successful in satisfying almost all of the design criteria. It was able to control the 
application of cyclic synchronized tensile and compressive loads between 0 – 0.2N at 
frequencies between 0.25 – 1Hz with an error of approximately 0.005N for gelatin 
samples. The bioreactor was able to reach equilibrium in less than 100 cycles and 
Figure 18: Accuracy of the force controlled stimulation over six hours of 
continuous operation. (A) Peak force accuracy (p = 0.000) (B) Force amplitude 
accuracy (p = 0.000) 
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maintain consistent force application for a six-hour period. The device fit inside of an 
incubator and was constructed from materials that can be sterilized with ethyl alcohol. 
The tissue stimulation chamber was able to fit samples between 10 – 40mm.  
The average error of applied force in tension using the rubber band was lower 
than the error using a gelatin sample, 0.003N vs. 0.005N (Figure 13, 15). Additionally, 
the largest standard deviation in force error for the rubber band test group was 
approximately 0.002N lower than for the gelatin sample test group (Figure 13 & 15). The 
rubber band has linear elastic material properties that create a consistent force response 
and overall less disturbance in the force control system. The increase in error when 
testing the gelatin was expected because the visco-elastic properties produce a time 
dependent force response for which the force control system must compensate. This test 
demonstrates one of the challenges of designing a control system that is not only stable 
but also accurately controls the forces applied to visco-elastic materials such as soft 
tissues. The force control system does not directly control the current signal to the 
actuators based off of force feedback, rather it adjusts the position set point sent to a 
position control loop based on the peak load and amplitude of the force waveform 
measured from applying the specific position waveform. As a result, only the peak and 
amplitude of the force waveform are controlled. A direct approach to force control could 
be used to control the complete force waveform applied to the sample; however, this 
would require a more sensitive load sensor and a higher speed execution rate to 
compensate for the visco-elastic response of the material. Additionally, the explicit 
approach would be much more susceptible to instability due to factors such as vibration 
and variable material properties. Given that the system is used for force controlled 
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stimulation applied for up to 6 hours at a time, system stability is critical. Thus a more 
stable system that only controls the peak and amplitude of force application was used as 
the primary force control method.  
To our knowledge, this is the first bioreactor that can apply synchronized multi-
axis stimulation in force control. Other multi-axis bioreactors have been developed to 
apply synchronized multi-axis stimulation [62,63]. While these devices measure the force 
applied to the tissue constructs, they cannot control the force they apply to the tissue; 
therefore, they cannot control the stress state applied to the tissue. A drawback of the 
device is that it can only stimulate one sample at a time. Given that the most in-vitro 
stimulation experiments take between 7 – 28 days to complete [49,52,53] this will hinder 
the experiment sample size that could be tested using the device in a feasible period of 
time. However, the device is small enough that it could be replicated to have multiple 
chambers operating in a single incubator.  
This study has limitations. The error of the force control above 0.2N was not 
evaluated because the gelatin samples tested were not strong enough to withstand cyclic 
application of loads greater than 0.2N. However, the force production capacity of the 
servo actuators is 4N of peak force; therefore, there was greater concern that the system 
would perform poorly at lower magnitudes of applied force. Further validation could be 
performed with a stiffer gel material to verify that the device could be used to forces 
greater than 0.2N. Additionally, while the displacement sequences for mechanical tests 
have been programmed and verified for functionality, the device was not used for any 
uniaxial tensile tests on fibroblast seeded tissue constructs. These tests will be performed 
in future experiments using the bioreactor. Furthermore, there is concern that the friction 
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from the loading platen and the compression platform could significantly alter the stress 
state applied to the sample. While the frictional effects have been mitigated through 
submerging the compression platform in fluid during testing, fixating a PTFE sheet to the 
compression platform, and machining the loading platen from PTFE the frictional effects 
have not been quantified and would require further validation. 
In conclusion, this study developed a multi-axis bioreactor that can apply force 
controlled stimulation to samples with a high degree of accuracy and precision. While the 
device performance has been validated outside of the incubator environment, the device 
still needs to be tested during an actual in-vitro experiment. Future work will focus on 
using the device to stimulate tissue surrogates to validate the device performance and to 
investigate the effects of deviatoric stress on structural and functional changes in 3D in-
vitro gels.  
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CHAPTER FOUR: MANUSCRIPT “A HAND-HELD DEVICE TO APPLY LOADS 
AT TARGETED MAGNITUDES AND STROKE FREQUENCIES DURING 
INSTRUMENT ASSISTED SOFT-TISSUE MOBILIZATION” 
4.1 Introduction 
Ligament and tendon tears account for over 50% of sporting injuries [81], and can 
lead to chronic impairments [3]. Instrument assisted soft tissue mobilization (IASTM) is 
a manual therapy technique frequently used in the fields of sports rehabilitation and 
athletic training [82]. Clinical studies have shown IASTM improves outcomes for 
individuals with shoulder and patellar tendinopathy [35,37], and chronic ankle pain [38]. 
In animal studies, IASTM has been shown to increase fibroblast proliferation [40,41] and 
accelerate the rate of functional restoration during healing [27]. Several IASTM 
techniques are currently practiced [83], and while each technique has minor differences 
in tools and treatment protocols, they all involve the manual application of dynamic 
compressive loads by cyclic stroking of the damaged tissue through the skin with an 
instrument. Notably, none of the prevalent IASTM techniques specify the loading 
parameters that are recommended during treatment, yet experiments using tissue analogs 
have demonstrated the mechanosensitivity of cells to the magnitude and strain-rate of 
applied forces [52,75]. Therefore, in order to identify IASTM loading parameters that 
result in optimal patient outcomes, it is important to develop devices that can accurately 
apply IASTM to targeted forces and stroke frequencies. 
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Current techniques to evaluate IASTM in a research setting include instrumented 
hand-held devices and robotic manipulators. Hand-held devices are practical, but have 
not yet been validated to apply targeted loads and stroke frequencies [27,41,42,68–
70,84]. Robotic manipulators can apply targeted loads and stroke frequencies [71,72], but 
these devices are stationary, expensive, and time intensive to operate, making them less 
practical for animal and human studies. The objective of this study was to develop a 
portable hand-held device that would enable users to accurately apply targeted forces and 
stroke frequencies during IASTM treatments. 
4.2 Methods 
4.2.1 Device Construction 
A portable device (Figure. 19A) was constructed with a custom machined 
aluminum tip, uniaxial force sensor (Omegadyne, Sunbury, OH; 10N), stainless steel 
shaft, data acquisition module (National Instruments, Austin TX, USA; cDAQ-9171 & 
NI9237), and a tablet computer. The aluminum tip has a beveled edge similar to clinical 
IASTM tools (Figure 19B). Device operators will first input the targeted treatment 
Figure 19: IASTM device design and components (A) Device components (B) 
Graston tool (C) Data acquisition and graphical user interface used with the device. 
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duration, peak compressive force, and stroke frequency into a custom LabVIEW program 
(Figure. 19C). The program then provides the operator feedback by displaying a live 
waveform of the applied load overlaid with a square waveform that shows the targeted 
loading profile. In 
addition, the program creates an auditory signal that indicates when to start and 
end a stroke, acting as a metronome to guide stroke frequency. Peak compressive force 
was calculated by averaging all the force values measured during contact, where contact 
was defined using an automated graded threshold algorithm to identify clustered regions 
of data points (Figure. 20A). Stroke frequency was calculated by using a Fourier series 
summation [80] to fit the raw force measurement data with a non-linear least squares 
fitting method (Figure. 20B). The data acquisition software is free to download 
(http://coen.boisestate.edu/ntm/software). 
4.2.2 Device Performance Tests 
Two tests were executed to evaluate device accuracy. The first test analyzed the 
Figure 20: Automated calculation of loading parameters. (A) Load data 
measured by the device during performance testing overlaid with the target loading 
profile. Black circles represent data included in the calculation of mean stroke force, 
while open circles were excluded from this calculation. (B) Fourier series fit for 
measured load data with target frequency of 0.5Hz. Note: the compressive load is 
applied every half cycle. 
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device’s accuracy in measuring compressive load when varying the angle between the 
device’s shaft and the surface being treated (i.e. shaft angle). This test was performed 
using fixtures to anchor the device at five fixed angles between 50-90 (Figure 21A). At 
each fixed angle, the device was manually loaded three times from 0-5N, while the force 
normal to the surface was simultaneously measured with an auxiliary force sensor 
(Instron, Norwood, MA, USA; 1kN; Figure 21A). Data was collected for three minutes. 
The second test determined the device’s accuracy in applying loads and stroke 
frequencies over a range of targeted values. This test was performed by having three 
individuals dynamically load a rigid foam block at eight different targeted loads (0.1-5N) 
and three different targeted frequencies (0.25, 0.5, 1.0 Hz). Each test was performed for 
one minute, and every test condition was performed three times by each operator. Each 
operator was allowed 30 minutes to practice using the device. In addition, a 1-minute 
practice run was performed prior to each test condition.  
Figure 21: Experimental setup. A) Device at a 60 deg shaft angle to determine 
error between the force measured by the device and the compressive load applied to 
a surface, which is measured by an auxiliary force sensor. B) Device in use during 
the rodent experiment 
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4.2.3 Experimental Validation 
In order to test the repeatability of the device in a research setting, a pilot study 
was conducted utilizing three Sprague-Dawley rats (age = 6 months). The device was 
used to perform IASTM to medial collateral ligaments (MCL) that were injured through 
surgical transection. A 2N force was applied along the length of the MCL, between the 
tibial and femoral insertion, at a rate of 1 Hz for 1-minute (Figure 21B). These IASTM 
treatments were repeated 5x times during a 3-week period, and were based on guidelines 
for the Graston technique [34]. All procedures were approved by the Institutional Animal 
Care and Use Committee of Boise State University (# 006-AC16-01).  
4.2.4 Statistical Tests 
The effect of shaft angle on the device’s accuracy in measuring compressive load 
was analyzed using linear regression. The effect of force magnitude, stroke frequency, 
and operator on the device’s accuracy in applying the targeted loading parameters were 
assessed using a MANOVA, with LSD post hoc analysis. The effect of treatment time on 
the measured loading parameters during the animal experiment was assessed using 
repeated measures ANOVA. For all statistical tests, significance was set at p<0.05 
4.3 Results 
4.3.1 Device Performance Tests 
For device shaft angles between 70-90, the device measurement error was less 
than 5%. Below 70 shaft angles, the device measurement error was greater than 15% 
(Figure 22A). Force was applied with less than 10% error for target magnitudes of 0.3 - 
5.0N. For forces below 0.3N, the error was greater than 15% (Figure 22B). The average 
standard deviation in percent error during each one-minute test dropped from 28% to 
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12% as load increased from 0.3 to 5.0N. There was no impact of stroke frequency on the 
percent error in applied force across all force magnitudes (p=0.94). The stroke frequency 
was accurately applied with less than 0.2% error for all target values (Table 4). Error 
decreased with increasing frequencies (Table 1; p=0.02). Additionally, changing 
operators had no effect on device accuracy (p=0.94).  
 
Table 4: Average stroke frequency across all tested loads (0.1-5.0N). The R2 
values are for the Fourier series summation fit of the measured load data.  
Target Frequency (Hz) Measured Frequency (Hz) Error (%) R2 
0.25 0.25 ± 0.01 0.13 ± 0.30 0.69 ± 0.14 
0.50 0.50 ± 0.01 0.09 ± 0.13 0.69 ± 0.16 
1.00 1.00 ± 0.01 0.04 ± 0.10 0.67 ± 0.14 
4.3.2 Experimental Validation 
The average percent error in load and stroke frequency across IASTM treatments 
was 4.5 ± 2.3% and 0.1 ± 0.1% respectively (Figure 23A). Additionally, there was no 
Figure 22: Results from device performance tests. (A) Comparison between the 
compressive force measured by the device and the compressive surface force 
measured by the auxiliary force sensor. A slope of 1 indicates the load measured by 
the device equals the compressive force applied to the surface. (B) Percent error in 
mean applied load at each targeted magnitude, averaged for three different 
operators. * = significantly different from all other targeted forces. 
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effect of time of treatment on device accuracy (p=0.32) (Figure 23B). At a 95% 
confidence interval, values for mean load across all treatments ranged between 2.0 and 
2.4 N. Therefore, there is 95% confidence that time of treatment and test subject had 
<10% effect on the mean load.  
 
4.4 Discussion 
This study developed a hand-held device that can accurately apply targeted forces 
and stroke frequencies during IASTM treatments. Important guidelines for use include: 1) 
using shaft angles greater than 70, where the device measurement error is less than 4%; 
and 2) applying targeted loads with compressive force between 0.3N–0.5N, where the 
error in applying a targeted load is less than 10%. Additionally, stroke frequencies of 1 
Hz or less can be targeted with less than 1% error. By designing a simple and intuitive 
device, this level of accuracy was achieved for new operators with only 30 minutes of 
practice. To assist the quick adoption of this device by scientists and clinicians, the data 
acquisition software that provides visual and audio feedback to operators is freely 
Figure 23: Results from experimental validation. (A) Average applied force and 
(B) average applied stroke frequency across five IASTM treatments for three rats. 
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available to download (http://coen.boisestate.edu/ntm/software). 
To our knowledge, this is the first hand-held device that has been validated to 
apply IASTM at targeted force magnitudes and stroke frequencies. Furthermore, this is 
the first study to demonstrate that these loading parameters can be repeatedly applied at 
multiple time points during in vivo animal experiments (Figure 23). Several researchers 
have prescribed forces during soft tissue mobilization through various techniques [40–
42,68,84]; however, none of these methods were validated to apply a targeted force or 
stroke frequency. A drawback of our hand-held device is that although a mean load could 
be accurately applied, the coefficient of variation during each test was 12-28% of the 
applied load (Figure 22B). Previous robotic manipulators have 5% less variation [69], but 
disadvantages of robotic manipulators include less flexibility in the applied stroke path 
and a greater setup time, which may preclude the testing of large sample sizes. 
This study has limitations. First, while the load range for the device is appropriate 
for many in-vivo research studies [40,41,52] and clinical studies of small joints [28], 
groups that want to apply loads greater than 10N would need to insert a different force 
sensor and conduct performance tests to determine device accuracy at higher force 
thresholds. Second, the hand-held device only measures normal force and would require a 
tri-axial force sensor to capture both normal and transverse force components [68]. 
However, this would increase device complexity and cost. Finally, while the sample size 
for the rat pilot study can estimate the device’s error in applying targeted loading 
parameters across multiple weeks of treatment (Figure 23), future studies would require 
larger sample sizes to measure the dose-effect of targeted IASTM treatments on the 
functional restoration of injured tissue.  
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In conclusion, a portable hand-held device was successfully developed to apply 
targeted loading magnitudes and stroke frequencies during IASTM treatments. This 
validated device can assist researchers investigating the effect of compressive force 
parameters (magnitude and rate) on wound healing, and can support the optimization of 
IASTM protocols to improve patient care.
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CHAPTER FIVE: CONCLUSIONS 
5.1 Summary 
The goal of this research was to develop in-vitro and in-vivo devices to determine 
optimal mechanical loading parameters to speed and strengthen healing of injured 
ligament. The in-vivo device is a hand-held device to control the frequency and 
magnitude of applied force during IASTM treatments. The device was validated to apply 
forces between 0 – 5N at frequencies from 0 – 1Hz with a high degree of accuracy and 
repeatability. The in-vitro device is a novel multi-axis mechanical stimulation bioreactor 
that can accurately apply tensile and combined tensile/compressive stress states to 3D 
fibroblast seeded tissue constructs. The bioreactor was validated to simultaneously apply 
cyclic forces from 0 – 0.2N with an accuracy of approximately 0.01N with a high degree 
of repeatability.  
5.2 Future Work 
5.2.1 In -Vivo Device 
The IASTM tool will be used in more comprehensive experiments using the same 
rat model but with a larger sample size and a wider range of applied forces and stroke 
frequencies so that definitive effects of the stimulation can be observed. 
5.2.2 In -Vitro Device 
The bioreactor will be used in preliminary experiments on fibroblast seeded tissue 
constructs. However, prior to executing the experiment a robust tissue construct needs to 
be developed that can withstand mechanical stimulation without failure and has a 
48 
 
 
microstructure that can be manipulated by the fibroblast cells. Additionally, an efficient 
experimental design needs to be developed to maximize through-put from the single 
stimulation chamber. 
Currently, a tissue construct created from collagen gel seeded with fibroblasts is 
being tested. The gels are seeded with NIH/3T3 mouse embryonic fibroblasts (ATCC, 
Manassas, VA) in to the collagen gel scaffold at 8.3 x 105 cells mL. The collagen scaffold 
has a collagen density of 1.45 mg/mL. The gels are created in dog bone shapes by casting 
them in custom molds (Figure 24A). The molds were machined from PTFE with a gauge 
width of 7 mm and gauge length of 21 mm (3:1 aspect ratio). Natural fiber pads (3M, St. 
Paul, MN) are placed in the ends of the mold to serve as mechanical constraints against 
cell driven contraction and to be used as a gripping surface in the bioreactor after the gels 
are removed from the molds (Figure 24B). 
 The current proposed experimental design would include two groups. The first 
group would be a control group of non-stimulated gels that would remain in their 
Figure 24: PTFE molds for collagen gel culture. (A) Empty mold (B) Mold with 
a cultured fibroblast seeded collagen gel (C) Collagen gel clamped in the 
bioreactor  
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respective molds for 14 days. The second group would be a mechanically stimulated 
group. The gels would be allowed 3 days to culture statically to become strong enough to 
tolerate mechanical stimulation. The gels would then be loaded in the bioreactor for 
mechanical stimulation for the remaining 11 days. The sample would only be loaded in 
tension and compression in one portion of the gel (Figure 25). After 14 days the samples 
will be mechanically tested in uniaxial tension to determine the elastic modulus of the 
tissue. The strain during the tensile test will be tracked through digital image correlation. 
The strain maps produce during the tensile tests are important because they will allow for 
the comparison of the stiffness of different regions of the gel. If the portion of the gel 
stimulated with combined loading has different strain behavior than the section loaded in 
only tension, then presumably there was some functional effect of the treatment.  
 
 
Figure 25: Proposed force controlled stimulation loading configuration. The 
loading platen only applies a compression to one half of the sample while the other 
half only received a tensile load. This allows the comparison of the effect of both 
loading conditions in one sample 
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